Cytonus Therapeutics is a cell-based platform technology focused on immune-oncology and gene therapies for devastative and rare diseases. This is achievable through Cytonus’ proprietary technology of a unique cell-line: the Cargocyte™.
Privately Funded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):